Girao Tiago 4
4 · Immunovant, Inc. · Filed May 5, 2025
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Girao Tiago
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-01+293,505→ 293,505 totalExercise: $15.90Exp: 2035-05-01→ Common Stock (293,505 underlying) - Award
Common Stock
2025-05-01+208,388→ 208,388 total
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 21, 2026 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.